Amylin and its analogues, most prominently cagrilintide, as a satiety mechanism orthogonal to incretin signalling. Includes the pharmacology of pramlintide as the historical reference point.
Conditions: ATTAIN-1 · tirzepatide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs…
For reference: SURMOUNT-5 · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
For reference: FLOW · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
The label documentation for the agent in question is ambiguous on exactly this point. This is one of those things that everyone repeats and nobody derives. This…
REDEFINE 1 reported mean weight loss of about 22.7% for CagriSema at 68 weeks, which as far as I can tell is the largest figure any phase 3 obesity trial has…
Setup, so nobody has to ask: SURPASS-2 · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
I am asking mechanistically rather than practically — I want the model, not the protocol. I can predict the outcome but I cannot explain it, which means I will get…
Details up front: mazdutide · FLOW. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident…
The specifics, since they change the answer: liraglutide · semaglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read…
Setup, so nobody has to ask: TRIUMPH-3 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
I am asking mechanistically rather than practically — I want the model, not the protocol. The comparison I want does not seem to exist anywhere in a form I can…
I have three data points across nine months, which I hope is enough to see a trend. I suspect the usual explanation for this is wrong, or at least incomplete. I am…
Details up front: SURMOUNT-1 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Conditions: 10 mg · tirzepatide. This is one of those things that everyone repeats and nobody derives. This matters practically, not just academically, because it…
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standards